Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:06:29.021Z.
Calculation as of: 2026-10-06T17:06:29.021Z.
Quote observation: 2026-10-06T16:58:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7a9a1b17caad0ab37430e79e816a911291535ac0fb348029df9f580b63ef335
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.29M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.29M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.12M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.53M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
